SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-055703
Filing Date
2021-11-09
Accepted
2021-11-09 16:02:41
Documents
16
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20211108.htm   iXBRL 8-K 44498
2 PRESS RELEASE acor-ex991_15.htm EX-99.1 555321
3 PRESS RELEASE acor-ex992_16.htm EX-99.2 21989
4 GRAPHIC g3s3gcoddgsr000001.jpg GRAPHIC 4764
5 GRAPHIC gul1d1bofylm000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-21-055703.txt   793631

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20211108.xsd EX-101.SCH 5677
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20211108_lab.xml EX-101.LAB 18595
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20211108_pre.xml EX-101.PRE 11029
9 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20211108_htm.xml XML 3422
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 211391968
SIC: 2836 Biological Products, (No Diagnostic Substances)